AIM Admission, £135 Million Placement
Advised stockbroker on the £135 million placing undertaken by a global pharmaceutical company and admission to the Alternative Investment Market (AIM).
Advised stockbroker on the £135 million placing undertaken by a global pharmaceutical company and admission to the Alternative Investment Market (AIM).